Database
User
| Toxicity | Dose | Time | Species | Model | Method | Action | Positive criterion | Reference |
|---|---|---|---|---|---|---|---|---|
| MEMBRANE POTENTIAL | 7.50±1.75 | human | qHTS-HepG2 | MMP assay | decrease | IC50 | 163 | |
| MEMBRANE POTENTIAL | 15.45 | human | HepG2 | MMP assay | decrease | IC50 | 163 | |
| MEMBRANE POTENTIAL | 13.02±1.06 | rat | hepatocytes | MMP assay | decrease | IC50 | 163 | |
| (6-Propoxy-benzothiazol-2-yl)-carbamic acid methyl ester | 61570-90-9 | AKOS000539060 |
| AX8154207 | BRD-K08404405-001-01-0 | CAS-61570-90-9 |
| CCG-103442 | CHEMBL1371412 | CTK5B3437 |
| Carbamic acid, (6-propoxy-2-benzothiazolyl)-, methyl ester | Carbamic acid,N-(6-propoxy-2-benzothiazolyl)-, methyl ester; | ChemDiv1_000106 |
| ChemDivAM_000281 | D06158 | DB11472 |
| DSSTox_CID_26178 | DSSTox_GSID_46178 | DSSTox_RID_81409 |
| DTXSID7046178 | EINECS 262-854-2 | HLLICFJUWSZHRJ-UHFFFAOYSA-N |
| HMS587E18 | MCULE-6592029073 | MLS004754522 |
| MLS006011641 | Methyl (6-propoxybenzo[d]thiazol-2-yl)carbamate | Methyl 6-propoxy-2-benzothiazolecarbamate |
| NCGC00160481-01 | NCGC00160481-02 | NZW046NI85 |
| Oprea1_503682 | Oprea1_841146 | Q27285133 |
| SCH 21480 | SCHEMBL23382 | SMR001353140 |
| SR-01000884010 | SR-01000884010-1 | ST50223266 |
| STK832929 | Sch-21480 | Tiox |
| Tiox (TN) | Tiox (Veterinary) | Tioxidazol |
| Tioxidazol [INN-Spanish] | Tioxidazole | Tioxidazole (USAN/INN) |
| Tioxidazole [USAN:INN] | Tioxidazolum | Tioxidazolum [INN-Latin] |
| Tox21_111843 | UNII-NZW046NI85 | ZINC1842639 |
| methoxy-N-(6-propoxybenzothiazol-2-yl)carboxamide | methyl (6-propoxy-1,3-benzothiazol-2-yl)carbamate | methyl-6-n-propoxybenzothiazole-2-carbamate |
| methyl-6-n-propyloxybenzothiazole-2-carbamate |